Rajat N Moman1, Daryl J Kor2, Arun Chandran3, Andrew C Hanson4, Darrell R Schroeder4, Alejandro A Rabinstein5, Matthew A Warner6. 1. Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, MN, USA. 2. Division of Critical Care Medicine, Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, MN, USA. 3. Department of Internal Medicine, Mount Auburn Hospital, Harvard Medical School, Cambridge, MA, USA. 4. Biostatistics, Department of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, USA. 5. Department of Neurology, Mayo Clinic, Rochester, MN, USA. 6. Division of Critical Care Medicine, Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, MN, USA. Electronic address: warner.matthew@mayo.edu.
Abstract
PURPOSE: Optimal red blood cell (RBC) transfusion thresholds in acute brain injury (ABI) are poorly defined. MATERIALS AND METHODS: We conducted a retrospective cohort study of adult patients with ABI and moderate anemia (Hb 7-10 g/dL) in a neurological intensive care unit (ICU) at an academic medical center between 2008 and 2015. Transfused and non-transfused patients were matched based on age, ABI subtype, pre-transfusion hemoglobin, and ICU length of stay (LOS) at the time of RBC transfusion. Multivariable regression analyses were performed to assess the relationship between RBC transfusion and hospital LOS, hospital mortality, ICU LOS, ICU mortality, and 24 h change in sequential organ failure assessment (SOFA) scores. RESULTS: 2638 patients met inclusion criteria, with 225 (8.5%) receiving RBC transfusion. Acute ischemic stroke was the most prevalent ABI diagnosis (43.3%) then intracranial hemorrhage (25.6%), subarachnoid hemorrhage (16.5%), and traumatic brain injury (TBI) (14.6%). In multivariable analyses, RBC transfusion was associated with longer hospital and ICU LOS, and higher SOFA scores. Each ABI subtype had similar results, except for TBI which showed no difference in hospital LOS. Mortality was not significantly different. CONCLUSIONS: In moderately anemic patients with ABI, RBC transfusion was associated with longer hospital and ICU LOS. Prospective investigations are necessary to further assess these relationships.
PURPOSE: Optimal red blood cell (RBC) transfusion thresholds in acute brain injury (ABI) are poorly defined. MATERIALS AND METHODS: We conducted a retrospective cohort study of adult patients with ABI and moderate anemia (Hb 7-10 g/dL) in a neurological intensive care unit (ICU) at an academic medical center between 2008 and 2015. Transfused and non-transfused patients were matched based on age, ABI subtype, pre-transfusion hemoglobin, and ICU length of stay (LOS) at the time of RBC transfusion. Multivariable regression analyses were performed to assess the relationship between RBC transfusion and hospital LOS, hospital mortality, ICU LOS, ICU mortality, and 24 h change in sequential organ failure assessment (SOFA) scores. RESULTS: 2638 patients met inclusion criteria, with 225 (8.5%) receiving RBC transfusion. Acute ischemic stroke was the most prevalent ABI diagnosis (43.3%) then intracranial hemorrhage (25.6%), subarachnoid hemorrhage (16.5%), and traumatic brain injury (TBI) (14.6%). In multivariable analyses, RBC transfusion was associated with longer hospital and ICU LOS, and higher SOFA scores. Each ABI subtype had similar results, except for TBI which showed no difference in hospital LOS. Mortality was not significantly different. CONCLUSIONS: In moderately anemicpatients with ABI, RBC transfusion was associated with longer hospital and ICU LOS. Prospective investigations are necessary to further assess these relationships.
Authors: Santiago Ramón Leal-Noval; María Dolores Rincón-Ferrari; Ana Marin-Niebla; Aurelio Cayuela; Victoria Arellano-Orden; Antonio Marín-Caballos; Rosario Amaya-Villar; Carmen Ferrándiz-Millón; Francisco Murillo-Cabeza Journal: Intensive Care Med Date: 2006-09-22 Impact factor: 17.440
Authors: Jason J Sico; John Concato; Carolyn K Wells; Albert C Lo; Steven E Nadeau; Linda S Williams; Aldo J Peixoto; Mark Gorman; John L Boice; Dawn M Bravata Journal: J Stroke Cerebrovasc Dis Date: 2011-11-18 Impact factor: 2.136
Authors: David A Zygun; Jurgens Nortje; Peter J Hutchinson; Ivan Timofeev; David K Menon; Arun K Gupta Journal: Crit Care Med Date: 2009-03 Impact factor: 7.598
Authors: Joshua Levine; Andrew Kofke; Liyi Cen; Zhen Chen; Jennifer Faerber; J Paul Elliott; H Richard Winn; Peter Le Roux Journal: Neurosurgery Date: 2010-02 Impact factor: 4.654
Authors: Andreas H Kramer; Matthew J Gurka; Bart Nathan; Aaron S Dumont; Neal F Kassell; Thomas P Bleck Journal: Crit Care Med Date: 2008-07 Impact factor: 7.598
Authors: Tiffany R Chang; Amelia K Boehme; Aimee Aysenne; Karen C Albright; Christopher Burns; T Mark Beasley; Sheryl Martin-Schild Journal: Springerplus Date: 2013-08-13
Authors: Chulho Kim; Sang-Hwa Lee; Jae-Sung Lim; Mi Sun Oh; Kyung-Ho Yu; Yerim Kim; Ju-Hun Lee; Min Uk Jang; San Jung; Byung-Chul Lee Journal: J Clin Med Date: 2020-05-21 Impact factor: 4.241